1. Home
  2. ACXP vs XELB Comparison

ACXP vs XELB Comparison

Compare ACXP & XELB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • XELB
  • Stock Information
  • Founded
  • ACXP 2017
  • XELB 2011
  • Country
  • ACXP United States
  • XELB United States
  • Employees
  • ACXP N/A
  • XELB N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • XELB Multi-Sector Companies
  • Sector
  • ACXP Health Care
  • XELB Miscellaneous
  • Exchange
  • ACXP Nasdaq
  • XELB Nasdaq
  • Market Cap
  • ACXP 6.8M
  • XELB 6.4M
  • IPO Year
  • ACXP 2021
  • XELB N/A
  • Fundamental
  • Price
  • ACXP $4.12
  • XELB $1.44
  • Analyst Decision
  • ACXP Strong Buy
  • XELB
  • Analyst Count
  • ACXP 3
  • XELB 0
  • Target Price
  • ACXP $143.67
  • XELB N/A
  • AVG Volume (30 Days)
  • ACXP 67.3K
  • XELB 81.4K
  • Earning Date
  • ACXP 11-12-2025
  • XELB 08-14-2025
  • Dividend Yield
  • ACXP N/A
  • XELB N/A
  • EPS Growth
  • ACXP N/A
  • XELB N/A
  • EPS
  • ACXP N/A
  • XELB N/A
  • Revenue
  • ACXP N/A
  • XELB $5,774,000.00
  • Revenue This Year
  • ACXP N/A
  • XELB $53.01
  • Revenue Next Year
  • ACXP N/A
  • XELB $20.46
  • P/E Ratio
  • ACXP N/A
  • XELB N/A
  • Revenue Growth
  • ACXP N/A
  • XELB N/A
  • 52 Week Low
  • ACXP $3.80
  • XELB $0.95
  • 52 Week High
  • ACXP $44.00
  • XELB $8.49
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 36.61
  • XELB 53.28
  • Support Level
  • ACXP $4.09
  • XELB $1.37
  • Resistance Level
  • ACXP $4.34
  • XELB $1.51
  • Average True Range (ATR)
  • ACXP 0.45
  • XELB 0.08
  • MACD
  • ACXP 0.10
  • XELB 0.01
  • Stochastic Oscillator
  • ACXP 8.73
  • XELB 69.57

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

Share on Social Networks: